XOMA Corporation (XOMA) - Pangali EV/EBITDA

The market price confirmed by this chart demonstrates an EV/EBITDA multiple of 92.49, highlighting the role of XOMA (XOMA) as a financial ally to the biotech sector through the acquisition of rights to future payments. The business relies on an asset-light model, accumulating patents and milestone bonuses without incurring research costs. This structure provides full protection against inflation and expenses by linking profits to the market success of partners' drugs.

XOMA XOMA Corporation: Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 25.07.2026

Rincian metrik lan analitis perusahaan xoma.com (XOMA)

- rega pasar lan target rega analis:

Bagan rega XOMA Royalty Corporation|XOMA - Konsensus nilai wajar

- indikator kapitalisasi pasar:

Kapitalisasi pasar XOMA|XOMA - Total Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham XOMA Royalty|XOMA - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku xoma.com|XOMA - Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas XOMA Royalty|XOMA - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas XOMA Royalty Corporation|XOMA - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku XOMA|XOMA - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan XOMA Royalty|Indikator likuiditas cepet xoma.com

- data bathi bisnis lan rasio investasi:

XOMA - Bathi perusahaan|Bathi sing dikarepake XOMA Royalty|XOMA - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep XOMA Royalty Corporation|XOMA - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA XOMA|XOMA - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan XOMA Royalty|XOMA - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan xoma.com|XOMA - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep XOMA Royalty

- indikator volume dodolan lan pendapatan:

XOMA - Total pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan XOMA Royalty Corporation|XOMA - Rega marang dodolan|Multiplikator Forward P/S XOMA

Ringkesan analisis perusahaan:XOMA Corp XOMA

Produk sing diprodhuksi XOMA Royalty Corporation

XOMA Royalty specializes in antibody licensing and high-tech biomedical analysis. This metric compares the total enterprise value with its operating income, neutralizing the impact of debt load and taxes. The price action of the EV/EBITDA valuation multiple reflects the market's revaluation of scientific capital between quarterly reports. Monitoring this metric allows an investor to promptly identify the fundamental undervaluation of assets and avoid the risks of portfolio overconcentration.

Pesaing XOMA Royalty (XOMA)